Barrow Hanley Mewhinney & Strauss LLC lowered its stake in shares of HealthSouth Corp (NYSE:HLS) by 3.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,374,465 shares of the company’s stock after selling 49,981 shares during the period. Barrow Hanley Mewhinney & Strauss LLC owned 1.40% of HealthSouth worth $63,706,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of HLS. TimesSquare Capital Management LLC purchased a new stake in shares of HealthSouth during the second quarter worth $37,868,000. APG Asset Management N.V. purchased a new stake in shares of HealthSouth during the third quarter worth $27,082,000. William Blair Investment Management LLC lifted its position in shares of HealthSouth by 13.9% during the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after acquiring an additional 525,767 shares in the last quarter. Balyasny Asset Management LLC lifted its position in shares of HealthSouth by 421.4% during the second quarter. Balyasny Asset Management LLC now owns 618,311 shares of the company’s stock worth $29,926,000 after acquiring an additional 499,715 shares in the last quarter. Finally, Marshall Wace North America L.P. lifted its position in shares of HealthSouth by 311.3% during the second quarter. Marshall Wace North America L.P. now owns 560,568 shares of the company’s stock worth $26,907,000 after acquiring an additional 424,280 shares in the last quarter. Hedge funds and other institutional investors own 93.37% of the company’s stock.
Several equities research analysts have issued reports on HLS shares. Royal Bank of Canada restated a “buy” rating on shares of HealthSouth in a research report on Wednesday, November 15th. Zacks Investment Research upgraded HealthSouth from a “hold” rating to a “buy” rating and set a $52.00 target price on the stock in a research report on Monday, October 30th. Mizuho upgraded HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 target price on the stock in a research report on Thursday, November 2nd. ValuEngine downgraded HealthSouth from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Finally, Piper Jaffray Companies reiterated a “hold” rating and issued a $50.00 price objective on shares of HealthSouth in a research report on Sunday, September 17th. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. HealthSouth currently has a consensus rating of “Hold” and an average price target of $51.75.
HealthSouth (NYSE:HLS) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The company had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. During the same quarter last year, the business posted $0.65 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year. analysts expect that HealthSouth Corp will post 2.72 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be given a $0.25 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.00%. HealthSouth’s dividend payout ratio (DPR) is presently 36.36%.
In other HealthSouth news, Director Yvonne M. Curl acquired 1,000 shares of the stock in a transaction that occurred on Wednesday, November 1st. The shares were bought at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the transaction, the director now owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.60% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/12/17/barrow-hanley-mewhinney-strauss-llc-sells-49981-shares-of-healthsouth-corp-hls.html.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.